Boulder, Colorado — According to state and local economic development sources AGC Biologics plans to invest $100,000,000.00 to build out new space in Boulder. The company plans to occupy the new space at 5550 Airport Blvd. in Boulder, on or about April 1, 2021. According to the company website AGC Biologics offers deep industry expertise and uniquely customized services for the scale up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems. Our integrated service offerings include cell line development, bioprocess development, formulation, analytical testing, antibody drug development and conjugation, cell banking and storage and protein expression including our proprietary CHEF1 Expression System for efficient protein production with CHO cells.

To learn more about AGC Biologics, visit http://www.agcbio.com/

Company Contact:
Patricio Massera, Chief Executive Officer
https://www.linkedin.com/in/pmassera/
425-485-1900

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved